VERU logo

Veru (VERU) Company Overview

Profile

Full Name:

Veru Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 11, 1999

Indexes:

Not included

Description:

Veru Inc. is a biopharmaceutical company focused on developing innovative medicines for men's and women's health. They work on treatments for prostate cancer, sexual health, and other conditions. Veru aims to improve patient outcomes through research and advanced therapies.

Key Details

Price

$0.59

Annual Revenue

$16.89 M(+3.62% YoY)

Annual EPS

-$0.28(+74.55% YoY)

Annual ROE

-145.40%

Beta

2.13

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Dec 5, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Apr 28, 2014
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 2, 25 HC Wainwright & Co.
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Nov 5, 24 Oppenheimer
Outperform
May 14, 24 B. Riley Securities
Buy
May 13, 24 HC Wainwright & Co.
Buy
May 6, 24 HC Wainwright & Co.
Buy
Apr 15, 24 Oppenheimer
Outperform
Mar 28, 24 Raymond James
Outperform
Feb 8, 24 HC Wainwright & Co.
Buy
Sep 27, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Veru?
  • Does Veru pay dividends?
  • What sector is Veru in?
  • What industry is Veru in?
  • What country is Veru based in?
  • When did Veru go public?
  • Is Veru in the S&P 500?
  • Is Veru in the NASDAQ 100?
  • Is Veru in the Dow Jones?
  • When was Veru's last earnings report?
  • When does Veru report earnings?
  • Should I buy Veru stock now?

What is the ticker symbol for Veru?

The ticker symbol for Veru is NASDAQ:VERU

Does Veru pay dividends?

No, Veru does not pay dividends

What sector is Veru in?

Veru is in the Healthcare sector

What industry is Veru in?

Veru is in the Biotechnology industry

What country is Veru based in?

Veru is headquartered in United States

When did Veru go public?

Veru's initial public offering (IPO) was on February 11, 1999

Is Veru in the S&P 500?

No, Veru is not included in the S&P 500 index

Is Veru in the NASDAQ 100?

No, Veru is not included in the NASDAQ 100 index

Is Veru in the Dow Jones?

No, Veru is not included in the Dow Jones index

When was Veru's last earnings report?

Veru's most recent earnings report was on Feb 13, 2025

When does Veru report earnings?

The next expected earnings date for Veru is May 8, 2025

Should I buy Veru stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions